These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Cancer after kidney transplantation]. Sandrini S; Setti G; Bossini N; Maiorca P G Ital Nefrol; 2004; 21 Suppl 26():S67-73. PubMed ID: 15732048 [TBL] [Abstract][Full Text] [Related]
25. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats. Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305 [TBL] [Abstract][Full Text] [Related]
26. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196 [TBL] [Abstract][Full Text] [Related]
27. The relative effects of different systemic immunosuppressives on skin cancer development in organ transplant patients. Durando B; Reichel J Dermatol Ther; 2005; 18(1):1-11. PubMed ID: 15842607 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
29. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression. Stallone G; Infante B; Grandaliano G; Schena FP; Gesualdo L Transpl Int; 2008 Sep; 21(9):825-32. PubMed ID: 18498314 [TBL] [Abstract][Full Text] [Related]
30. [Screening for skin cancer in organ transplant recipients in Denmark]. Horn J; Lock-Andersen J; Rasmussen K; Jemec GB Ugeskr Laeger; 2005 Jun; 167(25-31):2762-5. PubMed ID: 16014261 [TBL] [Abstract][Full Text] [Related]
31. Organ transplantation and skin cancer: basic problems and new perspectives. Hofbauer GF; Bouwes Bavinck JN; Euvrard S Exp Dermatol; 2010 Jun; 19(6):473-82. PubMed ID: 20482618 [TBL] [Abstract][Full Text] [Related]
32. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654 [TBL] [Abstract][Full Text] [Related]
33. [Immunosuppressive drugs and the development of skin cancer after organ transplantation]. Gjersvik P; Helsing P; Holdaas H; Bergan S Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2064-8. PubMed ID: 23038197 [TBL] [Abstract][Full Text] [Related]
34. The impact of mTOR inhibitors on the development of malignancy. Geissler EK Transplant Proc; 2008 Dec; 40(10 Suppl):S32-5. PubMed ID: 19100904 [TBL] [Abstract][Full Text] [Related]
35. Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma. Martinez JC; Otley CC; Euvrard S; Arpey CJ; Stasko T; Dermatol Surg; 2004 Apr; 30(4 Pt 2):662-6. PubMed ID: 15061852 [TBL] [Abstract][Full Text] [Related]
36. Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks. Otley CC; Griffin MD; Charlton MR; Edwards BS; Neuburg M; Stasko T; Br J Dermatol; 2007 Dec; 157(6):1183-8. PubMed ID: 17916206 [TBL] [Abstract][Full Text] [Related]
37. Effect of low-dose rapamycin on tumor growth in two human hepatocellular cancer cell lines. Heuer M; Benkö T; Cicinnati VR; Kaiser GM; Sotiropoulos GC; Baba HA; Treckmann JW; Broelsch CE; Paul A Transplant Proc; 2009; 41(1):359-65. PubMed ID: 19249557 [TBL] [Abstract][Full Text] [Related]
38. Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis. Marimpietri D; Brignole C; Nico B; Pastorino F; Pezzolo A; Piccardi F; Cilli M; Di Paolo D; Pagnan G; Longo L; Perri P; Ribatti D; Ponzoni M Clin Cancer Res; 2007 Jul; 13(13):3977-88. PubMed ID: 17606732 [TBL] [Abstract][Full Text] [Related]
39. First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation. Trösch F; Rothenburger M; Schneider M; Welp H; Etz C; Wilhelm MJ; Scheld HH; Schmid C Thorac Cardiovasc Surg; 2004 Jun; 52(3):163-8. PubMed ID: 15192777 [TBL] [Abstract][Full Text] [Related]
40. Management of skin cancer in solid organ transplant recipients. Traywick C; O'Reilly FM Dermatol Ther; 2005; 18(1):12-8. PubMed ID: 15842608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]